ZSL Symposium on Amphibian Pathogens

Mitigating single pathogen and co-infections that threaten amphibian biodiversity

24 Apr – 25 Apr 2019

Zoological Society of London, Regents Park, London. 

Amphibians continue to experience worldwide declines and remain the most threatened vertebrate class. Nearly 30 years of research has shown that pathogens, in particular chytridiomycete fungi and ranaviruses, are responsible for infectious diseases that cause catastrophic population and host community declines on all continents where amphibians exist. While our understanding of the conditions required for amphibian-host decline has grown significantly, our ability to convert this knowledge into practical strategies for managing amphibian pathogens lags far behind. In contrast, the pathogens are moving quickly, and beginning to emerge as mixed infections, causing even greater declines.

This two-day symposium is the first international event to approach chytrids and ranaviruses as a combined threat to amphibians. It will drawn on key research communities, as well as on-the-ground conservationists, to aid the process of moving beyond single pathogen research and management, into managing mixed infections and potentially competing pathogens. Speakers will outline the conservation issues amphibians face and how disease figures in these, provide background on the threat posed by single versus mixed pathogen dynamics, and the outcomes of field mitigation strategies. This symposium will bring together the amphibian research and conservation communities to develop 21st century strategies for combating rapidly emerging mixed infections that are already threatening global amphibian biodiversity.

For more information on this event, visit this link.

Wellcome Centre Anti-Infectives Research Conference

WCAIR_Conference_web_872x340

Venue

University of Dundee

Dates

12 - 15 May 2019

 

The first conference of the Wellcome Centre for Anti-Infectives Research aims to harness cross-disciplinary and cross-disease learning to accelerate drug discovery and reduce drug candidate attrition rates for infectious diseases affecting low and middle income countries. Conference attendees will take home new ideas and technologies which have been demonstrated to work; applying them to diseases where challenges to drug discovery are hampering progress.

The conference has been formatted to allow active participation of all conference delegates. Each session will feature talks from internationally recognised experts followed by a panel discussion providing the opportunity for the audience to discuss the issues raised with the speakers. There will also be plenty of networking opportunities through poster sessions and evening social events.

The organising committee encourage researchers working within disease endemic countries to attend and bring their first-hand knowledge of the impact of infectious diseases to the discussions. 20 travel bursaries worth up to £1,500 are available to those coming from low and middle income countries to assist with the costs of attending the conference. Thank you to MMV, DNDi, Novartis BioMedical Research Institute and the Bill & Melinda Gates Foundation for sponsoring the travel bursaries.

Further information on registration, travel bursaries and abstract submission can be found on the conference website http://www.lifesci.dundee.ac.uk/research/events/wcair-conference-2019 .

Deadlines

Abstract Submission

Short-talks: 31st October 2018

Posters: 31st December 2018

Registration

Early Bird, closes 30th November 2018: £300

Registration from 1st December 2018: £375

Registration closes: 5th April 2019

Invited Speakers

Bree Aldridge, Tufts University, Boston; Clif Barry, National Institute of Allergy and Infectious Diseases, Bethesda; Manu De Rycker, University of Dundee; Natalie Gobeau, Medicines for Malaria Venture; Paul Herrling; Jennifer Keiser, Swiss Tropical and Public Health Institute; Paul Leeson, Medicinal Chemistry Consultant; Didier Leroy, Medicines for Malaria Venture; James McCarthy, QIMR Berghofer Medical Research Institute, Brisbane; Valerie Mizrahi, University of Cape Town; John Overington, Medicines Discovery Catapult; John Pottage, ViiV Healthcare; Isabela  Ribeiro, Drugs for Neglected Diseases initiative; Lynn Silver, Anti-bacterial consultant; Thomas Spangenberg, Merck Global Health Institute; Shyam Sundar, Banaras Hindu University, Varanasi; Wesley Van Voorhis, University of Washington; Sir Nicholas White, Mahidol University, Thailand and Oxford University, UK; Susan Wyllie, University of Dundee.

 

Follow @WCAIRDundee #SOSID2019 for latest information on the conference.